Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11

Mantle cell lymphoma (MCL) shows a clinical aggressiveness that varies from patient to patient. Despite major advances in outcomes with current immunochemotherapy, the future development of therapies requires risk stratification to tailor therapy intensity. Within the group of reference pathologists...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Virchows Arch
Autors principals: Croci, Giorgio A., Hoster, Eva, Beà, Sílvia, Clot, Guillem, Enjuanes, Anna, Scott, David W., Cabeçadas, José, Veloza, Luis, Campo, Elias, Clasen-Linde, Erik, Goswami, Rashmi S., Helgeland, Lars, Pileri, Stefano, Rymkiewicz, Grzegorz, Reinke, Sarah, Dreyling, Martin, Klapper, Wolfram
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7415076/
https://ncbi.nlm.nih.gov/pubmed/31975037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00428-020-02750-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars